N-[1-(2-dimethylaminoethyl)-1-H-indole-7-yl]-naphtalene-1-sulfonamide | 844486-21-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: N-[1-(2-dimethylaminoethyl)-1-H-indole-7-yl]-naphtalene-1-sulfonamide
• 英文别名: N-[1-(2-dimethylaminoethyl)-1H-indole-7-yl]-naphtalene-1-sulfonamide；N-[1-[2-(dimethylamino)ethyl]indol-7-yl]naphthalene-1-sulfonamide
• CAS: 844486-21-1
• 化学式: C₂₂H₂₃N₃O₂S
• 分子量: 393.51
• InChiKey: WVEMMZJMQTUIHS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  28
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  62.7
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  7-amino-(2-dimethylaminoethyl)-1H-indole 、 1-萘磺酰氯 在 N,N-二异丙基乙胺 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 20.0h， 以51%的产率得到N-[1-(2-dimethylaminoethyl)-1-H-indole-7-yl]-naphtalene-1-sulfonamide
  参考文献：
  名称：

  [EN] ACTIVE SUBSTANCE COMBINATION COMPRISING A COMPOUND WITH NPY RECEPTOR AFFINITY AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY
  [FR] COMBINAISON DE SUBSTANCES ACTIVES COMPORTANT UN COMPOSE A AFFINITE DE RECEPTEUR NPY ET UN COMPOSE A AFFINITE DE RECEPTEUR 5-HT6

  摘要：

  本发明涉及一种活性物质组合，包括至少一种具有神经肽Y受体亲和力的化合物和至少一种具有5-HT6受体亲和力的化合物，以及包含所述活性物质组合的药物和利用该活性物质组合制造药物的用途。

  公开号：

  WO2005014000A1

文献信息

• [EN] ACTIVE SUBSTANCE COMBINATION COMPRISING A COMPOUND WITH NPY RECEPTOR AFFINITY AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY<br/>[FR] COMBINAISON DE SUBSTANCES ACTIVES COMPORTANT UN COMPOSE A AFFINITE DE RECEPTEUR NPY ET UN COMPOSE A AFFINITE DE RECEPTEUR 5-HT6
  申请人：ESTEVE LABOR DR

  公开号：WO2005014000A1

  公开（公告）日：2005-02-17

  The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity and at least one compound with 5-HT6 receptor affinity, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.

  本发明涉及一种活性物质组合，包括至少一种具有神经肽Y受体亲和力的化合物和至少一种具有5-HT6受体亲和力的化合物，以及包含所述活性物质组合的药物和利用该活性物质组合制造药物的用途。
• Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
  申请人：Torrens Jover Antoni

  公开号：US20070009597A1

  公开（公告）日：2007-01-11

  The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity, preferably neuropeptide Y5-receptor affinity, and at least one compound with 5-HT 6 receptor affinity, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.

  本发明涉及一种活性物质组合，包括至少一种具有神经肽Y受体亲和力的化合物，优选为神经肽Y5受体亲和力，以及至少一种具有5-HT6受体亲和力的化合物，一种包含该活性物质组合的药物，以及使用该活性物质组合制造药物。
• Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
  申请人：Merce Vidal Ramon

  公开号：US20070185207A1

  公开（公告）日：2007-08-09

  The present invention refers to new sulfonamide derivatives, of general formula (1a, 1b, ic), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salts, preferably the corresponding, physiologically acceptable salts, or corresponding solvates; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.

  本发明涉及新的磺酰胺衍生物，一般式为（1a，1b，ic），可以是它们的立体异构体之一，优选是对映异构体或二对映异构体，它们的外消旋体，或者以任何混合比例的至少两种立体异构体，优选是对映异构体或二对映异构体的混合物，或它们的盐，优选是相应的生理上可接受的盐，或相应的溶剂化物；以及它们的制备方法，作为人类和/或兽医治疗药物的应用，以及含有它们的制药组合物。
• Indol-7-YL sulfonamide derivatives, their preparation and their use in pharmaceutical compositions
  申请人：Laboratorios del Dr. ESTEVE S.A.

  公开号：US07414070B2

  公开（公告）日：2008-08-19

  The present invention refers to new sulfonamide derivatives, of general formula (Ia, Ib, Ic), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salts, preferably the corresponding, physiologically acceptable salts, or corresponding solvates; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.

  本发明涉及新的磺酰胺衍生物，通式为(Ia，Ib，Ic)，可选择其中一种立体异构体形式，优选对映异构体或二对映异构体，它们的混合物，其中至少包含两种立体异构体，优选对映异构体或二对映异构体，任意混合比例，或它们的盐，优选相应的生理可接受盐，或相应的溶剂合物；以及它们的制备方法，它们在人类和/或兽医治疗中作为药物的应用，以及含有它们的制药组合物。
• ACTIVE SUBSTANCE COMBINATION COMPRISING A COMPOUND WITH NPY RECEPTOR AFFINITY AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY
  申请人：Torrens Jover Antoni

  公开号：US20120128768A1

  公开（公告）日：2012-05-24

  The present invention relates to an active substance combination comprising at least one compound with neuropeptide Y-receptor affinity and at least one compound with 5-HT6 receptor affinity, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament.

  本发明涉及一种活性物质组合物，包括至少一种具有神经肽Y受体亲和力的化合物和至少一种具有5-HT6受体亲和力的化合物，以及包含该活性物质组合物的药物和使用该活性物质组合物制造药物的用途。